R. Netea-Maier

between treatment and systemic inflammation in acromegaly.

A. Hoischen, O. Pînzariu, C. Jacobs, 2021 .

Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease

A. Hoischen, L. Joosten, J. Veltman, 2017, Clinical pharmacology and therapeutics.

The association between treatment and systemic inflammation in acromegaly.

A. Hoischen, M. Netea, D. Thijssen, 2021, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas.

R. Netea-Maier, H. Timmers, E. V. van Lindert, 2013, European journal of endocrinology.

Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease.

C. Sweep, M. den Heijer, R. Netea-Maier, 2006, European journal of endocrinology.

Impaired quality of life in patients in long-term remission of Cushing's syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?

M. den Heijer, R. Netea-Maier, J. Prins, 2012, European journal of endocrinology.

Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly

R. Netea-Maier, J. Smit, A. Hermus, 2015, Pituitary.